Charles Francavilla
Novartis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Charles Francavilla.
Bioorganic & Medicinal Chemistry Letters | 2009
Charles Francavilla; Eddy Low; Satheesh K. Nair; Bum Tae Kim; Timothy P. Shiau; Dmitri Debabov; Chris Celeri; Nichole J. Alvarez; Ashley Houchin; Ping Xu; Ron Najafi; Rakesh K. Jain
A series of backbone modified and sulfonic acid replacement analogs of our topical, clinical candidate (iii) were synthesized. Their antimicrobial activities and aqueous stabilities at pH 4 and pH 7 were determined, and has led us to identify quaternary ammonium N,N-dichloroamines as a new class of topical antimicrobial agents.
Bioorganic & Medicinal Chemistry Letters | 2011
Timothy P. Shiau; Eric D. Turtle; Charles Francavilla; Nichole J. Alvarez; Meghan Zuck; Lisa Friedman; Donogh J.R. O’Mahony; Eddy Low; Mark B. Anderson; Ramin Najafi; Rakesh K. Jain
Antimicrobial resistance against many known therapeutics is on the rise. We examined derivatives of 3-chlorooxazolidin-2-one 1a (X=H) as antibacterial and antifungal agents. The key findings were that the activity and apparent in vitro cytotoxicity could be controlled by the substitution of charged solubilizers at the 4- and 5- positions. These changes both significantly increase the antifungal potency and decrease cytotoxicity. Particularly effective were trialkylammonium groups which led to 400- to 600-fold increases in the antifungal therapeutic index when compared to their unsubstituted counterparts.
Antimicrobial Agents and Chemotherapy | 2013
Andreas Jekle; Jungjoo Yoon; Meghan Zuck; Ramin Najafi; Lu Wang; Timothy P. Shiau; Charles Francavilla; Suriani Abdul Rani; Christian Eitzinger; Markus Nagl; Mark S. Anderson; Dmitri Debabov
ABSTRACT Bacterial pathogens have specific virulence factors (e.g., toxins) that contribute significantly to the virulence and infectivity of microorganisms within the human hosts. Virulence factors are molecules expressed by pathogens that enable colonization, immunoevasion, and immunosuppression, obtaining nutrients from the host or gaining entry into host cells. They can cause pathogenesis by inhibiting or stimulating certain host functions. For example, in systemic Staphylococcus aureus infections, virulence factors such as toxic shock syndrome toxin 1 (TSST-1), staphylococcal enterotoxin A (SEA), and staphylococcal enterotoxin B (SEB) cause sepsis or toxic shock by uncontrolled stimulation of T lymphocytes and by triggering a cytokine storm. In vitro, these superantigens stimulate the proliferation of human peripheral blood mononuclear cells (PBMC) and the release of many cytokines. NVC-422 (N,N-dichloro-2,2-dimethyltaurine) is a broad-spectrum, fast-acting topical anti-infective agent against microbial pathogens, including antibiotic-resistant microbes. Using mass spectrometry, we demonstrate here that NVC-422 oxidizes methionine residues of TSST-1, SEA, SEB, and exfoliative toxin A (ETA). Exposure of virulence factors to 0.1% NVC-422 for 1 h prevented TSST-1-, SEA-, SEB-, and ETA-induced cell proliferation and cytokine release. Moreover, NVC-422 also delayed and reduced the protein A- and clumping factor-associated agglutination of S. aureus cultures. These results show that, in addition to its well-described direct microbicidal activity, NVC-422 can inactivate S. aureus virulence factors through rapid oxidation of methionines.
Bioorganic & Medicinal Chemistry Letters | 2011
Charles Francavilla; Eric D. Turtle; Bum Tae Kim; Donogh J.R. O’Mahony; Timothy P. Shiau; Eddy Low; Nichole J. Alvarez; Chris Celeri; Louisa D’Lima; Lisa Friedman; Francis S. Ruado; Ping Xu; Meghan Zuck; Mark B. Anderson; Ramin Najafi; Rakesh K. Jain
Antimicrobial compounds with broad-spectrum activity and minimal potential for antibiotic resistance are urgently needed. Toward this end, we prepared and investigated a novel series of N-chloroheterocycles. Of the compounds examined, the N-chloroamine series were found superior over N-chloroamide series in regards to exhibiting high antimicrobial activity, low cytotoxicity, and long-term aqueous stability.
Bioorganic & Medicinal Chemistry Letters | 2013
Timothy P. Shiau; Eddy Low; Bum Tae Kim; Eric D. Turtle; Charles Francavilla; Donogh J.R. O’Mahony; Lisa Friedman; Louisa D’Lima; Andreas Jekle; Dmitri Debabov; Meghan Zuck; Nichole J. Alvarez; Mark S. Anderson; Ramin Najafi; Rakesh K. Jain
The discovery and development of antimicrobial agents that do not give rise to resistance remains an ongoing challenge. Our efforts in this regard continue to reveal new potential therapeutic agents with differing physicochemical properties while retaining the effective N,N-dichloroamine pharmacophore as the key antimicrobial warhead. In this Letter, we disclose agents containing polyol units as a water solubilizing group. These sulfonyl-polyol agents show broad spectrum bactericidal and virucidal activity. These compounds show 1 h MBCs of 16-512 μg/mL against Escherichia coli and 4-256 μg/mL against Staphylococcus aureus at neutral pH, and 1-h IC50s of 4.5-32 μM against Adenovirus 5 and 0.7-3.0 μM against Herpes simplex virus 1. The lead compounds were tested in a tissue culture irritancy assay and showed only minimal irritation at the highest concentrations tested.
Bioorganic & Medicinal Chemistry Letters | 2011
Eddy Low; Bum Tae Kim; Charles Francavilla; Timothy P. Shiau; Eric D. Turtle; Donogh John Roger O'mahony; Nichole J. Alvarez; Ashley Houchin; Ping Xu; Meghan Zuck; Chris Celeri; Mark B. Anderson; Ramin Najafi; Rakesh K. Jain
Structure stability/activity relationships (SXR) of a new class of N,N-dichloroamine compounds were explored to improve antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans while maintaining aqueous solution stability. This study identified a new class of solution-stable and topical antimicrobial agents. These agents are sulfone-stabilized and possess either a quaternary ammonium or sulfonate appendages as a water solubilizing group. Several unique challenges were confronted in the synthesis of these novel compounds which are highlighted in the discussion.
Archive | 2006
Rakesh K. Jain; Mikhail Fedorovich Gordeev; Jason G. Lewis; Charles Francavilla
Archive | 2009
Rakesh K. Jain; Eddy Low; Charles Francavilla; Timothy P. Shiau; Satheesh K. Nair
Archive | 2009
Rakesh K. Jain; Eddy Low; Charles Francavilla; Timothy P. Shiau; Bum Tae Kim; Satheesh K. Nair
Archive | 2006
Kathryn Rene Bracken; Simon Bushell; Karl Dean; Charles Francavilla; Rakesh K. Jain; Kwangho Lee; Mohindra Seepersaud; Lei Shu; Arathia Sundaram; Zhengyu Yuan